Max Robotics — Global Service Robot Directory + US Certification

About

Anusha Garapaty is pioneering the frontier of oral biotherapeutic delivery, addressing one of the most persistent challenges in modern medicine: the pain and inconvenience of chronic injections. Her most-cited work, a 2021 study on a robotic pill for oral biotherapeutic delivery, has garnered 94 citations and represents a paradigm shift in patient care. This innovative device is designed to safely and effectively transport large-molecule drugs—typically degraded by the gastrointestinal tract—directly into systemic circulation, offering a needle-free alternative for managing chronic diseases. Garapaty’s research bridges engineering and pharmacology, demonstrating not only the tolerability and performance of this robotic platform in healthy subjects but also its potential to dramatically improve patient compliance. Her contributions are particularly impactful for conditions requiring frequent injections, such as diabetes or autoimmune disorders, where adherence is critical. By tackling the longstanding barrier of oral biotherapeutic instability, Garapaty is redefining what’s possible in drug delivery, earning recognition as a rising leader in translational biomedical innovation.